June 24, 2015

In the U.S., bioMérieux Introduces New Lyme Disease Diagnostic Tests

New VIDAS® Lyme Assays Provide Differential Detection and Allow Classification of the Infection...Read More

June 22, 2015

Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux

For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobia...Read More

April 14, 2015

BioFire Submits De Novo Application to FDA for FilmArray® Meningitis/Encephalitis Panel

...Read More

February 26, 2015

BioFire Receives FDA Clearance for the FilmArray® 2.0 System

New system delivers higher throughput, single database management and minimized footprint...Read More

November 18, 2014

bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections

bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they ha...Read More

November 13, 2014

Get Smart About Antibiotics Week 2014

Get Smart About Antibiotics Week is an annual one-week observance to raise awareness of antibiotic resistance and the importa...Read More

May 08, 2014

“VITEK MS: Changing the Face of Clinical Microbiology” Webinar NOW AVAILABLE

...Read More

May 05, 2014

BioFire's FilmArray® Gastrointestinal Panel Receives FDA Clearance

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its new molecular biology aff...Read More

October 01, 2013

U.S. FDA Clearance Received for VITEK® MS, a Revolutionary Technology that Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics

New technology made possible by a Nobel Prize winning discovery holds the promise to improve clinical decision-making for inf...Read More

April 15, 2013

A Rare Case of Carbapenem-Resistant Enterobacteriaceae on the West Coast Quickly Identified by VITEK ®2

The VITEK 2 provides a community of public hospitals with a level of expertise that is usually only available at large urban ...Read More

October 15, 2012

bioMérieux Installs its 10,000th VITEK® 2 Compact Unit at Washington, D.C. Public Health Lab

This month, bioMérieux installed its 10,000th VITEK® 2 Compact worldwide. ...Read More

October 15, 2012

Introducing Etest® CPT: MIC susceptibility testing for ceftaroline fosamil

bioMérieux is pleased to announce the release of Etest® CPT for susceptibility testing of Teflaro®. ...Read More

October 15, 2012

MALDI-TOF: New Technology For RUO Identification

MALDI-TOF is an automated mass spectrometry and software system designed for rapid microbial identification....Read More

October 15, 2012

chromID® Strepto B Improves Sensitivity and Makes Detection of GBS Easier

Identifying pregnant women who carry Group B Streptococcus (GBS) is crucial, because mothers can transmit GBS to the baby dur...Read More

August 15, 2012

Agar-Based Testing by an MIC Method Critical to the Management of Cystic Fibrosis Patients

bioMérieux spoke with Dr. Blake Buchan about the specific issues surrounding antibiotic susceptibility testing for CF isolat...Read More

August 15, 2012

New VITEK® 2 GN AST Cards Available

The new formulation of Piperacillin/Tazobactam (Pip/Tazo) has been granted market clearance by the FDA, and will be offered o...Read More

August 15, 2012

MALDI-TOF Draws a Crowd at ASM 2012

bioMérieux’s In-Booth Knowledge Forum at the 2012 ASM featured two exciting talks on MALDI-TOF Mass Spectrometry by Dr. Me...Read More

March 15, 2012

Streamlined QC Guidelines for API® Strips

The Clinical Laboratory Standards Institute (CLSI™) published a new QC guideline, CLSI standard M50A ...Read More

March 15, 2012

bioMérieux Unveils Exciting Additions to the Family of Chromogenic Media

Introducing chromID™ S. aureus, chromID™ P. aeruginosa , and chromID™ salmonella ...Read More

January 15, 2012

bioMérieux Expands Infectious Disease and Molecular Test Offering with Acquisition of ARGENE

bioMérieux is excited to welcome the ARGENE infectious disease line to our family of products....Read More

November 15, 2011

Update on FDA-cleared Molecular Assays Supported

bioMérieux’s NucliSENS® easyMAG® has been widely adopted across the U.S. as an automated nucleic acid extraction platfor...Read More

November 15, 2011

A Unique Lab Depends on VITEK® 2 for its Unique Patients

Bako Pathology Services is a physician-founded and owned laboratory offering a wide array of anatomic pathology and clinical ...Read More

September 15, 2011

VITEK® PC5.01 — Increased Capabilities and Speed Make the VITEK® 2 Even More Valuable

Features prove crucial for lab efficiency and quality control...Read More

September 15, 2011

bioMérieux Introduces the First FDA-Cleared Toxoplasmosis Avidity Test in the U.S.

The VIDAS® TOXO IgG Avidity assay can be used to exclude a recently acquired toxoplasmosis infection in pregnant women...Read More

September 15, 2011

NucliSENS® EasyQ® MRSA — Improved Design and Robust Performance in a Rapid Molecular Screening Assay

bioMérieux recently received FDA clearance of the NucliSENS® EasyQ® MRSA assay, a qualitative in vitro diagnostic test for...Read More

July 15, 2011

Total AST

Find the best VITEK® 2 and Etest® combination to meet your needs....Read More

July 15, 2011

New VITEK® 2 Cards

The expanded VITEK® 2 menu now includes 20 Gram Negative (GN) cards with an array of new antibiotic combinations....Read More

July 15, 2011

VITEK® PC 5.01 — A Welcome Boost to the Microbiology Workhorse

The Vitek PC 5.01 is easier to work with and more intuitive and includes a remote viewer....Read More

July 15, 2011

New VITEK® 2 PC5.01 Software Release: A Major Leap Forward

bioMérieux’s new software release for the VITEK® 2 PC has features designed to help you become more efficient by saving y...Read More

July 15, 2011

Mass Spectrometry: Cutting Edge Microbial Identification

A new method has emerged that can reduce identification to a few minutes....Read More

May 15, 2011

bioMérieux chromID™ CPS Media: Enhanced Identification and Rapid Reporting of Urinary Tract Pathogens for Excellence in Patient Care

bioMérieux’s chromID CPS agar is a ready-to-use, chromogenic media that allows for the differentiation of different bacter...Read More

March 15, 2011

Exciting New Media from bioMérieux

bioMerieux will soon be introducing the newest addition to our chromID™ line of chromogenic media. ...Read More

March 15, 2011

Utilizing VITEK®2 bioART® Rules To Enhance Accurate Susceptibility Reporting

bioART® rules can be easily built as required so there is true real-time quality assurance....Read More

December 15, 2010

New VITEK® 2 Cards —Expanding and Improving Testing Capabilities

bioMérieux announces the availability of new Gram-positive and Gram-negative antibiotic susceptibility testing (AST) cards. ...Read More

December 15, 2010

Troubleshooting False Vancomycin Resistance

Tips to prevent falsely elevated vancomycin MICs in your laboratory....Read More

December 15, 2010

Observa® – VITEK® 2 Increases Database Capabilities and Result Process Management

The system consolidates the results from our BacT/ALERT® 3D microbial detection system and VITEK® 2 automated microbial ide...Read More

July 15, 2010

A Closer Look at MYLA™

Myla™ is an intelligent microbiology middleware solution that is designed by microbiologists for microbiologists. ...Read More

July 15, 2010

PC 5.01: Another Leap Forward in VITEK 2 Software Capabilities

VITEK® 2 System PC5.01 offers improved workflow via multi-user remote access. ...Read More

May 15, 2010

Introducing MYLA™: an innovative software solution helping to recapture your time

Myla™ is an intelligent microbiology middleware solution that is designed by microbiologists for microbiologists. ...Read More

February 15, 2010

Etest Voriconazole FDA Clearence

Voriconazole is triazole antifungal medication developed by Pfizer® that is used to treat serious, invasive fungal infection...Read More

February 15, 2010

NucliSENS® easyMAG™: Now FDA-cleared for Use With New Molecular Parainfluenza Virus Assay

The number of nucleic acid diagnostic assays for which the easyMAG System is labeled for use continues to grow with the recen...Read More

February 15, 2010

Introducing VILINK

VILINK™ provides new services for the monitoring and optimization of diagnostic devices....Read More

February 01, 2010

Two New Cards Added to VITEK 2 Menu

We are always reviewing our menu of antibiotic susceptibility test (AST) cards to ensure they reflect the needs and practices...Read More

November 15, 2009

Product Spotlight: lyfoCults® Plus

Faster, Easier, Safer Approach to Quality Control...Read More

November 15, 2009

bioMérieux receives FDA Clearance For chromId™ MRSA

bioMérieux recently received FDA clearance for its Methicillin-resistant Staphyloccus aureus (MRSA) chromogenic media. ...Read More

July 15, 2009

Product Spotlight: Etest™

Etest is used to determine the Minimum Inhibitory Concentration (MIC) of antibiotics, antifungal agents and antimycobacterial...Read More

July 15, 2009


Now Labeled For Use In Front Of A New Nucleic Acid Test For Detection Of Toxigenic Clostridium difficile...Read More

July 15, 2009

bioMérieux Customer Support Services now fully supports PML Microbiologicals Prepared Media and LyfoCults® QC Organisms

...Read More

November 15, 2008

VIDAS® C. difficile Toxin A&B (CDAB) Assay

At the 108th American Society of Microbiology general meeting June 1-5, 2008, bioMérieux presented a poster on the VIDAS® C...Read More

October 15, 2008

Etest® Celebrates 20th Anniversary

Twenty years ago, in October of 1988, an ingenious product was created that changed the world of antimicrobial susceptibility...Read More

June 15, 2008

The Door Opens Wider for Molecular Infectious Disease Testing

...Read More

June 15, 2008

NucliSENS® easyMAG Validated with Both FDA-Cleared Respiratory Viral Assays

System Supports Automated Nucleic Acid Extraction For Use with Prodesse ProFlu+TM and Luminex xTAGTM RVP Assays...Read More

April 15, 2008

New Vidas® Assays

bioMérieux Receives FDA Clearance for VIDAS® C. difficile Toxin A&B Assay and VIDAS® Troponin I Ultra Assay....Read More

April 15, 2008

FDA Clears bioMérieux’s VIDAS® NT-proBNP Assay

bioMérieux received 510(k) clearance from the U.S. Food and Drug Administration to market VIDAS® NT-proBNP, a test that aid...Read More

February 15, 2008

bioMérieux Promotes Antibiotic Stewardship at American Society for Health-System Pharmacists Midyear Meeting

The 2007 American Society for Health-System Pharmacists (ASHP) Midyear Meeting was held in Las Vegas, and bioMérieux’s und...Read More

December 15, 2007

Dispensing Advice with Medication

Pharmacists use patient management software to intervene for better and more responsible patient care....Read More

October 15, 2007

The Use of Expert Systems in an Era of Increasing Antibiotic Resistance

...Read More

August 15, 2007

Data Driven Drug Decisions

In the scientific world of medicine where so much of our practice is evidence based, the choice and dosing of pharmaceuticals...Read More

June 15, 2007

DiversiLab System: Strain Typing

The DiversiLab‚ System for DNA fingerprinting and analysis is a powerful tool for tracking the spread and source of microbi...Read More

June 15, 2007

Macrolides and Related Antibiotics

The macrolides have been known for more than five decades and since the introduction in therapy of erythromycin, a number of ...Read More

June 15, 2007

Scotland chooses VITEK® 2

A division of NHS National Services Scotland and the Scottish Microbiology Forum have awarded bioMérieux with a major contra...Read More

April 15, 2007

New Developments in Automated Nucleic Acid Extraction

Deliver Quality Results and Improve Productivity in the Molecular Diagnostic Laboratory....Read More

February 15, 2007

Fluconazole Susceptibility Testing of Candida: Automated Testing has Finally Come of Age

...Read More

December 15, 2006

Emerging Resistance

Emerging resistance and the presence of new resistance mechanisms create a need for new antibiotics and new detection methods...Read More

December 15, 2006

Comparison of Phoenix and Vitek® 2 Compact

For Performance and Identification and Susceptibility Testing, Workflow and Time to Report...Read More

October 15, 2006


...Read More

October 15, 2006

Antibiotic resistance due to carbapenemases

The emergence of carbapenem-resistant Klebsiella pneumoniae can be added to the growing list of highly resistant organisms....Read More

October 15, 2006

NucliSENS® easyMAG™ receives 2nd Award from Frost & Sullivan

bioMérieux is proud to be recognized as the recipient of Frost & Sullivan’s 2006 North American Clinical Diagnositcs Produ...Read More

October 15, 2006

bioMérieux offers new molecular infectious disease products

NucliSENS® Primer/Probe Mix Analyte Specific Reagents (ASRs) for Mycoplasma pneumoniae, Chlamydia pneumonia and Herpes Simpl...Read More

September 15, 2006

Update on fungal susceptibility testing

The number of serious infections due to yeasts continues to increase...Read More

September 15, 2006

bioMérieux establishes an Organism Surveillance Network

bioMérieux Organism Resistance Initiative Surveillance network will work to specifically address the issues of emerging anti...Read More

September 15, 2006

Analysis of the Comparative Workflow and ID/AST Test Result Accuracy of the VITEK® 2 Compact and the PHOENIX™ Systems

...Read More

September 15, 2006

VRSA screen test for VITEK® 2 now FDA approved

This test predicts the presence of high levels of Vancomycin resistance....Read More

September 15, 2006

Rapid Automated Identification of Neisseria gonorrhoeae Fresh Isolates with the New VITEK® 2 NH Card.

...Read More

May 15, 2006

NucliSENS® easyMAG™ receives Frost & Sullivan Technology Innovation Award

bioMérieux is proud to be recognized as the recipient of Frost & Sullivan’s 2006 Technology Innovation Award in the field ...Read More

February 15, 2006

Neisseria species, haemophilus species and other fastidious organisms identified on VITEK®2

The VITEK 2 NH ID card identifies 28 species of bacteria....Read More

February 15, 2006

Are VITEK® 2 MICs “Real” MICs?

There are microbiologists who question the validity of the VITEK® 2 method of antimicrobial susceptibility testing....Read More

December 15, 2005

Realizing the potential of computerized ‘expert’ systems for interpreting antimicrobial susceptibility testing data

...Read More

September 15, 2005

Why I chose VITEK® 2 for my laboratory

Doctors Laboratory, Inc. in Valdosta, Georgia is choosing VITEK 2 to be their ID/AST system for the next 12-plus years....Read More

July 15, 2005

Reducing upper-extremity strain: VITEK® 2 tops MicroScan® 96

...Read More

July 15, 2005

ECCMID posters show excellent performance of VITEK® 2 Colorimetric Cards

Two posters presented at the European Congress of Clinical Microbiology and Infectious Diseases conference illustrate the exc...Read More

April 15, 2005

How can we identify resistance? Improving susceptibility testing

...Read More

April 15, 2005

SXT As mentioned in the last newsletter, clinical trials have been completed with trimethoprim/sulfamethoxazole (SXT), and the data has been submitted to the U.S. Food and Drug Administration (FDA). W

bioMérieux is pleased to introduce two new VITEK®1 Gram negative susceptibility test cards and one new Gram positive suscep...Read More

February 15, 2005

What’s in the works for molecular labs? Real-time NASBA analyte specific reagents!

...Read More

February 15, 2005

VITEK® 2 cards with confirmatory ESßL test

The test utilizes Cefotaxime, Ceftazidime and Cefepime – with and without Clavulanic Acid....Read More

November 15, 2004

Not all d-dimer assays are created equal and neither are their units!

...Read More

November 15, 2004

VIDAS®D-Dimer Exclusion™receives Clinical Diagnostics Product Innovation of the Year award

This award is bestowed on the company that successfully develops a product that is believed to provide a unique set of benefi...Read More

November 15, 2004

Ergonomic study reveals VITEK® 2 causes significantly less upper-extremity strain than other system

...Read More

September 15, 2004

Introducing the first of a new generation of nucleic acid extraction instruments: the NucliSens® miniMAG

The NucliSens® miniMAG takes advantage of bioMérieux’s proprietary Boom chemistry in combination with magnetic silica par...Read More

July 15, 2004

Exclusion of DVT and PE – a first! Only from bioMérieux

D-Dimer Exclusion™ is the first and only D-dimer assay to be cleared in the U.S. for exclusion of a diagnosis of both deep ...Read More